Moser, Russell J’s team published research in Organic Mass Spectrometry in 1970 | 112-63-0

Organic Mass Spectrometry published new progress about 112-63-0. 112-63-0 belongs to class esters-buliding-blocks, and the molecular formula is C19H34O2, Application of C19H34O2.

Moser, Russell J.; Brown, Ellis Vincent published the artcile< Mass spectra of some 5- and 6-substituted 2-pyridinecarboxylic acids. Nature of fragmentation step for loss of carbon dioxide>, Application of C19H34O2, the main research area is pyridine carboxylic acid mass spectra.

The fragmentation patterns were obtained by electron-impact on 6-acetamido-, 6-amino-, 6-bromo-, 6-chloro-, 6-methoxy-, 6-methyl-, 6-nitro-, 5-carboxy-, 5-iodo-, 5-methoxy- and 5-nitro-2-pyridinecarboxylic acids, as well as 2- and 3-pyridinecarboxylic acids. Most of these acids lost CO2 [M – 44] as their first major fragmentation. This is in direct contrast to the substituted benzoic acids which show loss of OH [M – 17] or CO2H [M – 45] in their first major fragmentation. The ring N may determine which pathway predominates.

Organic Mass Spectrometry published new progress about 112-63-0. 112-63-0 belongs to class esters-buliding-blocks, and the molecular formula is C19H34O2, Application of C19H34O2.

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Lizarzaburu, Mike’s team published research in Bioorganic & Medicinal Chemistry Letters in 2012-09-15 | 112-63-0

Bioorganic & Medicinal Chemistry Letters published new progress about G protein-coupled receptors Role: BSU (Biological Study, Unclassified), BIOL (Biological Study) (GPR 142). 112-63-0 belongs to class esters-buliding-blocks, and the molecular formula is C19H34O2, Electric Literature of 112-63-0.

Lizarzaburu, Mike; Turcotte, Simon; Du, Xiaohui; Duquette, Jason; Fu, Angela; Houze, Jonathan; Li, Leping; Liu, Jinqian; Murakoshi, Michiko; Oda, Kozo; Okuyama, Ryo; Nara, Futoshi; Reagan, Jeff; Yu, Ming; Medina, Julio C. published the artcile< Discovery and optimization of a novel series of GPR142 agonists for the treatment of type 2 diabetes mellitus>, Electric Literature of 112-63-0, the main research area is alkylphenylalaninamide pyridinylphenylamine oxobipyridinylamine preparation GPR142 agonist; structure alkylphenylalaninamide pyridinylphenylamine oxobipyridinylamine GPR142 agonism exposure; cytochrome P 450 inhibition alkylphenylalaninamide pyridinylphenylamine oxobipyridinylamine.

N-alkylphenylalaninamides of pyridinylphenyl- and oxobipyridinylamines such as I were prepared as GPR142 agonists for potential use as antidiabetic agents for type 2 diabetes and tested for their agonism of GPR142 in vitro and in human plasma and their inhibition of cytochrome P 450 enzymes such as isoforms 3A4 and 2D6. Optimization of the original lead compound gave agonists 90 times more potent against human GPR142. Inhibition of cytochrome P 450 isoforms 3A4 and 2D6 was reduced by increasing the polarity of the biarylamine moiety. The pharmacokinetics of I and a thiazolylmethyl phenylalaninamide of an aminopyridinylbenzoate were determined in rats.

Bioorganic & Medicinal Chemistry Letters published new progress about G protein-coupled receptors Role: BSU (Biological Study, Unclassified), BIOL (Biological Study) (GPR 142). 112-63-0 belongs to class esters-buliding-blocks, and the molecular formula is C19H34O2, Electric Literature of 112-63-0.

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Iwasaki, Masayuki’s team published research in Organic Letters in 2013-10-18 | 112-63-0

Organic Letters published new progress about Aralkyl alcohols Role: RCT (Reactant), SPN (Synthetic Preparation), RACT (Reactant or Reagent), PREP (Preparation). 112-63-0 belongs to class esters-buliding-blocks, and the molecular formula is C19H34O2, Application of C19H34O2.

Iwasaki, Masayuki; Iino, Shohei; Nishihara, Yasushi published the artcile< Palladium-Catalyzed Annulation of o-Iodobiphenyls with o-Bromobenzyl Alcohols: Synthesis of Functionalized Triphenylenes via C-C and C-H Bond Cleavages>, Application of C19H34O2, the main research area is palladium phosphine catalyzed annulation iodobiphenyl bromobenzyl alc triphenylene; decarbonylative cross coupling intramol cyclization triphenylene synthesis.

Treatment of o-iodobiphenyls with o-bromobenzyl alcs. in the presence of cesium carbonate under palladium catalysis affords a series of highly substituted triphenylenes [e.g., o-iodobiphenyl + 2-(2-bromophenyl)-2-propanol in presence of PdCl2(NCPh)2/P[3,5-(CF3)2C6H3]3 and Cs2CO3 afforded triphenylene in 81% yield].. The reaction involves two C-C bond formations and C-C and C-H bond cleavages. A combination of palladium and an electron-deficient phosphine ligand proves to be effective for both decarbonylative cross-coupling and intramol. cyclization.

Organic Letters published new progress about Aralkyl alcohols Role: RCT (Reactant), SPN (Synthetic Preparation), RACT (Reactant or Reagent), PREP (Preparation). 112-63-0 belongs to class esters-buliding-blocks, and the molecular formula is C19H34O2, Application of C19H34O2.

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Li, Yan’s team published research in Energy Sources, Part A: Recovery, Utilization, and Environmental Effects in 2021 | 112-63-0

Energy Sources, Part A: Recovery, Utilization, and Environmental Effects published new progress about Biofuels. 112-63-0 belongs to class esters-buliding-blocks, and the molecular formula is C19H34O2, Related Products of 112-63-0.

Li, Yan; Wu, Weibo; Li, Hu; Zhao, Wenfeng; Yang, Song published the artcile< Sustainable and rapid production of biofuel γ-valerolactone from biomass-derived levulinate enabled by a fluoride-ionic liquid>, Related Products of 112-63-0, the main research area is biofuel valerolactone biomass derived levulinate fluoride ionic liquid.

γ-Valerolactone (GVL) is a versatile biomass-derived mol. for both value-added chems. and biofuels, which is typically prepared from levulinates over metal particles or oxides in the presence of hydrogen, formic acid or alc. Herein, we reported a rapid and mild approach for cascade hydrogenation-cyclization of Et levulinate (EL) to GVL in the presence of readily available ionic liquid tetrabutylammonium fluoride ([TBA]F) and polymethylhydrosiloxane (PMHS) as catalyst and hydrogen source, resp. After reacting at room temperature for 30 min, a high GVL yield of 85% with TOF value of 52 h-1 could be obtained over 3 mol% [TBA]F. In addition to optimizing reaction parameters, the catalytic mechanism was also elucidated for the one-pot sequential transformation of EL to GVL.

Energy Sources, Part A: Recovery, Utilization, and Environmental Effects published new progress about Biofuels. 112-63-0 belongs to class esters-buliding-blocks, and the molecular formula is C19H34O2, Related Products of 112-63-0.

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Iba, Hikari’s team published research in Journal of Pharmacological Sciences (Amsterdam, Netherlands) in 2021-01-31 | 112-63-0

Journal of Pharmacological Sciences (Amsterdam, Netherlands) published new progress about Amygdala. 112-63-0 belongs to class esters-buliding-blocks, and the molecular formula is C19H34O2, Product Details of C19H34O2.

Iba, Hikari; Watanabe, Takuya; Motomura, Saori; Harada, Kyoka; Uesugi, Haruka; Shibahara, Takenori; Kubota, Kaori; Katsurabayashi, Shutaro; Iwasaki, Katsunori published the artcile< A Japanese herbal medicine attenuates anxiety-like behavior through GABAA receptor and brain-derived neurotrophic factor expression in a rat model of premenstrual syndrome>, Product Details of C19H34O2, the main research area is premenstrual syndrome anxiety GABAA receptor neurotrophic factor expression; Anxiety; GABA(A) receptor β2-subunit; Herbal medicine; Premenstrual syndrome; Progesterone.

Inochinohaha White (IHW) is a Japanese herbal medicine for treating women with anxiety associated with premenstrual syndrome (PMS). In this study, we examined the effects of IHW on anxiety-like behavior in rats undergoing progesterone withdrawal (PWD), a model for PMS. Female rats were injected daily with progesterone for 21 days. Water and ethanol extracts of IHW (WE-IHW and EE-IHW, resp.) were administered orally 15 days after the initiation of progesterone injections. Anxiety-like behavior in an elevated plus maze was evaluated 48 h after the final injection of progesterone. PWD induced anxiety-like behavior, and EE-IHW (300 mg/kg), but not WE-IHW, significantly attenuated this behavior. Administration of the GABA agonists, diazepam or muscimol, significantly attenuated PWD-induced anxiety-like behavior. To investigate the underlying mechanisms of IHW action, we analyzed GABAA receptor expression in the amygdala of these rats. EE-IHW ameliorated the PWD-induced decrease in GABAA receptor β2-subunit mRNA, although β2-subunit protein was unchanged. Brain-derived neurotrophic factor (BDNF) has been reported to have anxiolytic effects and enhance GABAergic synaptic transmission. We found that EE-IHW increased BDNF levels in a dose-dependent manner. Our results suggest that EE-IHW attenuates PWD-induced anxiety-like behavior by increasing GABAA receptor-mediated signaling via increases in β2-subunit and BDNF in the amygdala.

Journal of Pharmacological Sciences (Amsterdam, Netherlands) published new progress about Amygdala. 112-63-0 belongs to class esters-buliding-blocks, and the molecular formula is C19H34O2, Product Details of C19H34O2.

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Proctor, Rupert S J’s team published research in Journal of the American Chemical Society in 2021-04-07 | 33402-75-4

Journal of the American Chemical Society published new progress about Amides Role: RCT (Reactant), SPN (Synthetic Preparation), RACT (Reactant or Reagent), PREP (Preparation). 33402-75-4 belongs to class esters-buliding-blocks, and the molecular formula is C8H9NO2, Recommanded Product: Methyl 4-methylnicotinate.

Proctor, Rupert S. J.; Chuentragool, Padon; Colgan, Avene C.; Phipps, Robert J. published the artcile< Hydrogen Atom Transfer-Driven Enantioselective Minisci Reaction of Amides>, Recommanded Product: Methyl 4-methylnicotinate, the main research area is amide heteroarene chiral phosphoric acid diacetyl light Minisci reaction; heteroarenyl alkyl amide stereoselective preparation.

Minisci-type reactions constitute one of the most powerful methods for building up complexity around basic heteroarenes. The most desirable variants involve formal oxidative coupling of a C-H bond on each partner, leading back to the simplest possible starting materials. We herein disclose a method that enables such a coupling of linear amides and heteroarenes with full control of enantioselectivity at the newly formed stereocenter as well as site selectivity on both the heteroarene and the amide. This is achieved by the use of a chiral phosphoric acid catalyst in conjunction with diacetyl as a combined hydrogen atom transfer reagent and oxidant. Diacetyl is directly photoexcitable, and thus, no extraneous photocatalyst is required: an added feature that contributes to the simplicity and practicality of the protocol.

Journal of the American Chemical Society published new progress about Amides Role: RCT (Reactant), SPN (Synthetic Preparation), RACT (Reactant or Reagent), PREP (Preparation). 33402-75-4 belongs to class esters-buliding-blocks, and the molecular formula is C8H9NO2, Recommanded Product: Methyl 4-methylnicotinate.

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Lu, Chuanjun’s team published research in Journal of Medicinal Chemistry in 2013-07-25 | 112-63-0

Journal of Medicinal Chemistry published new progress about Alzheimer disease. 112-63-0 belongs to class esters-buliding-blocks, and the molecular formula is C19H34O2, Related Products of 112-63-0.

Lu, Chuanjun; Guo, Yueyan; Yan, Jun; Luo, Zonghua; Luo, Hai-Bin; Yan, Ming; Huang, Ling; Li, Xingshu published the artcile< Design, Synthesis, and Evaluation of Multitarget-Directed Resveratrol Derivatives for the Treatment of Alzheimer's Disease>, Related Products of 112-63-0, the main research area is resveratrol derivative preparation Alzheimer treatment beta amyloid aggregation inhibitor; biometal chelator resveratrol derivative Alzheimer treatment; antioxidant resveratrol derivative Alzheimer treatment.

A series of multitarget-directed resveratrol derivatives was designed and synthesized for the treatment of Alzheimer’s disease (AD). In vitro studies indicated that most of the target compounds exhibit significant inhibition of self-induced β-amyloid (Aβ) aggregation and Cu(II)-induced Aβ1-42 aggregation and acted as potential antioxidants and biometal chelators. In particular, compounds I (R = Me) (II) and I (R = H) (III) are potential lead compounds for AD therapy (II, IC50 = 7.56 μM and III, IC50 = 6.51 μM for self-induced Aβ aggregation; the oxygen radical absorbance capacity assay using fluorescein (ORAC-FL) values are 4.72 and 4.70, resp.). Moreover, these compounds are capable of disassembling the highly structured Aβ fibrils generated by self- and Cu(II)-induced Aβ aggregation. Furthermore, II crossed the blood-brain barrier (BBB) in vitro and did not exhibit any acute toxicity in mice at doses of up to 2000 mg/kg. Taken together, the data indicate that II is a very promising lead compound for AD.

Journal of Medicinal Chemistry published new progress about Alzheimer disease. 112-63-0 belongs to class esters-buliding-blocks, and the molecular formula is C19H34O2, Related Products of 112-63-0.

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Le Rhun, Emilie’s team published research in Neuro-oncology in 2022-09-01 | 112-63-0

Neuro-oncology published new progress about 112-63-0. 112-63-0 belongs to class esters-buliding-blocks, and the molecular formula is C19H34O2, Computed Properties of 112-63-0.

Le Rhun, Emilie; Oppong, Felix Boakye; Vanlancker, Maureen; Stupp, Roger; Nabors, Burt; Chinot, Olivier; Wick, Wolfgang; Preusser, Matthias; Gorlia, Thierry; Weller, Michael published the artcile< Prognostic significance of therapy-induced myelosuppression in newly diagnosed glioblastoma.>, Computed Properties of 112-63-0, the main research area is anemia; chemoradiotherapy; lymphopenia; neutropenia; progression; survival; temozolomide; thrombocytopenia.

BACKGROUND: Myelosuppression is the major toxicity encountered during temozolomide chemoradiotherapy for newly diagnosed glioblastoma. METHODS: We assessed the association of myelosuppression (neutropenia, thrombocytopenia, anemia, and lymphopenia) during temozolomide chemoradiotherapy alone or in combination with experimental agents with progression-free survival (PFS) or overall survival (OS) in 2073 patients with newly diagnosed glioblastoma enrolled into five clinical trials: CENTRIC, CORE, EORTC 26082, AVAglio, and EORTC 26981. A landmark Cox model was used. For each primary association analysis, a significance level of 1.7% was used. RESULTS: Lower neutrophil counts at baseline were associated with better PFS (P = .011) and OS (P < .001), independently of steroid intake. Females experienced uniformly more myelotoxicity than males. Lymphopenia during concomitant chemoradiotherapy was associated with OS (P = .009): low-grade (1-2) lymphopenia might be associated with superior OS (HR 0.78, 98.3% CI 0.58-1.06), whereas high-grade (3-4) lymphopenia might be associated with inferior OS (HR 1.08, 98.3% CI 0.75-1.54). There were no associations of altered hematological parameters during concomitant chemoradiotherapy with PFS. During maintenance chemoradiotherapy, no significant association was found between any parameter of myelosuppression and PFS or OS, although exploratory analysis at 5% significance level indicated that either mild-to-moderate (HR 0.76, 95% CI 0.62-0.93) or high-grade lymphopenia (HR 0.65, 95% CI 0.46-0.92) was associated with superior OS (P = .013), but not PFS. CONCLUSIONS: The association of higher neutrophil counts at baseline with inferior PFS and OS requires further prospective evaluation. The link of therapy-induced lymphopenia to better outcome may guide the design for immunotherapy trials in newly diagnosed glioblastoma. Neuro-oncology published new progress about 112-63-0. 112-63-0 belongs to class esters-buliding-blocks, and the molecular formula is C19H34O2, Computed Properties of 112-63-0.

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Ji, Na’s team published research in Molecular Catalysis in 2020-11-30 | 112-63-0

Molecular Catalysis published new progress about Adsorption. 112-63-0 belongs to class esters-buliding-blocks, and the molecular formula is C19H34O2, Category: esters-buliding-blocks.

Ji, Na; Liu, Zhenyu; Diao, Xinyong; Bao, Jinrong; Yu, Zhihao; Song, Chunfeng; Liu, Qingling; Ma, Degang; Lu, Xuebin published the artcile< A novel Ni/AC catalyst prepared by MOCVD method for hydrogenation of ethyl levulinate to γ-valerolactone>, Category: esters-buliding-blocks, the main research area is nickel catalyst prepared vapor deposition ethyl levulinate hydrogenation valerolactone.

GVL (γ-valerolactone) is identified as an important biomass platform mol. due to its wide application. In this work, a series of novel supported Ni catalysts with different supports and Ni loading were synthesized via metal-organic chem. vapor deposition (MOCVD) method for the hydrogenation of EL (Et levulinate) to GVL. Fourier transform IR spectroscopy, X-ray powder diffraction, nitrogen adsorption/desorption, inductively coupled plasma optical emission spectroscopy and transmission electron microscopy were used to characterize the as-synthesized catalysts. The results showed that the 2 weight% Ni/AC(MOCVD) presented superior catalytic activity when compared with the catalyst prepared by impregnation method. This behavior is explained in terms of the smaller Ni nanoparticles (4.28 nm) and higher dispersion on 2 weight% Ni/AC(MOCVD). Among the catalysts, the 2 weight% Ni/AC catalyst exhibited the best catalytic performance with 99.7% EL conversion and 79.8% GVL yield under 1 MPa initial H2 pressure (measured at room temperature) at 250°C for 2 h. In addition, the reaction conditions were optimized and the stability of the catalyst were also investigated. The insights gained from this study in the design of high dispersed Ni particles with smaller particle size via MOCVD method will facilitate the metal-catalyzed hydrogenation of EL to GVL.

Molecular Catalysis published new progress about Adsorption. 112-63-0 belongs to class esters-buliding-blocks, and the molecular formula is C19H34O2, Category: esters-buliding-blocks.

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Bamborough, Paul’s team published research in ACS Medicinal Chemistry Letters in 2016-06-09 | 112-63-0

ACS Medicinal Chemistry Letters published new progress about Antitumor agents (potential as). 112-63-0 belongs to class esters-buliding-blocks, and the molecular formula is C19H34O2, HPLC of Formula: 112-63-0.

Bamborough, Paul; Barnett, Heather A.; Becher, Isabelle; Bird, Mark J.; Chung, Chun-wa; Craggs, Peter D.; Demont, Emmanuel H.; Diallo, Hawa; Fallon, David J.; Gordon, Laurie J.; Grandi, Paola; Hobbs, Clare I.; Hooper-Greenhill, Edward; Jones, Emma J.; Law, Robert P.; Le Gall, Armelle; Lugo, David; Michon, Anne-Marie; Mitchell, Darren J.; Prinjha, Rab K.; Sheppard, Robert J.; Watson, Allan J. B.; Watson, Robert J. published the artcile< GSK6853, a Chemical Probe for Inhibition of the BRPF1 Bromodomain>, HPLC of Formula: 112-63-0, the main research area is GSK6853 inhibitor BRPF1 bromodomain; BET; BRD1; BRPF1; BRPF2; BRPF3; bromodomain; chemical probe; epigenetics; inhibitor.

The BRPF (Bromodomain and PHD Finger-containing) protein family are important scaffolding proteins for assembly of MYST histone acetyltransferase complexes. A selective benzimidazolone BRPF1 inhibitor showing micromolar activity in a cellular target engagement assay was recently described. Herein, we report the optimization of this series leading to the identification of a superior BRPF1 inhibitor suitable for in vivo studies.

ACS Medicinal Chemistry Letters published new progress about Antitumor agents (potential as). 112-63-0 belongs to class esters-buliding-blocks, and the molecular formula is C19H34O2, HPLC of Formula: 112-63-0.

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics